ACXP

ACURX PHARMACEUTICALS INC

ACXP·00510M203·US·Common Stock·Healthcare - Biotechnology-13D/G

ACXP (ACURX PHARMACEUTICALS INC) is held by 12 institutional investors as of Q1 2026. Largest holders: JANE STREET GROUP, LLC ($202,722), VANGUARD CAPITAL MANAGEMENT LLC ($115,377), GEODE CAPITAL MANAGEMENT, LLC ($92,080). Net institutional sentiment: Mixed.

12
Holders
$529,283
Total Value
60% (10)
Consensus
6 buying - 4 selling
13F: Insider & Congress:
ACXPSmart Money Verdict
View all
Held by 12 funds
Who's Trading
ActivistARArmistice Capital, LLC5.0%Nov 14, 2025
ActivistARArmistice Capital, LLC10.0%Aug 14, 2025
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
54,642(+408.6%)$202,7220.0%-11.98%
25
New
31,099$115,3770.0%+1.35%
34
Increased
24,819(+99.9%)$92,0800.0%-26.84%
24
New
16,205$60,1210.0%+1.35%
32
Unchanged
6,500$24,1150.0%-93.84%
0
Increased
6,312(+3634.9%)$23,4180.0%-0.70%
21
Unchanged
2,300$8,5330.0%-42.75%
0
New
380$1,4100.0%+1.35%
17
Decreased
245(-13.4%)$9090.0%-84.58%
0
Unchanged
100$3710.0%-97.67%
0
Unchanged
60$2230.0%-89.93%
0
Unchanged
1$40.0%-64.95%
0
Exited
0(-100.0%)$42,1160.0%-43.51%
0
Exited
0(-100.0%)$103,1530.0%-43.51%
0
Exited
0(-100.0%)$420.0%-84.13%
0

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used